{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:31:42Z","timestamp":1769110302298,"version":"3.49.0"},"reference-count":34,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2017]]},"DOI":"10.1536\/ihj.16-290","type":"journal-article","created":{"date-parts":[[2017,3,16]],"date-time":"2017-03-16T22:18:20Z","timestamp":1489702700000},"page":"211-219","source":"Crossref","is-referenced-by-count":5,"title":["Effects of Long-Acting Loop Diuretics in Heart Failure With Reduced Ejection Fraction Patients With Cardiac Resynchronization Therapy"],"prefix":"10.1536","volume":"58","author":[{"given":"Masahiko","family":"Asami","sequence":"first","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Aoki","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuzou","family":"Tanimoto","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Horiuchi","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Watanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Furui","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Yasuhara","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuyuki","family":"Sato","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kengo","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Hara","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Mitsui Memorial Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Franco G, Biagio F, Battista ZG, <i>et al<\/i>. ALERT-HF: adherence to guidelines in the treatment of patients with chronic heart failure. J Cardiovasc Med 2014; 15: 491-7.","DOI":"10.2459\/JCM.0000000000000038"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Freis ED. The efficacy and safety of diuretics in treating hypertension. Ann Intern Med 1995; 122: 223-6. (Review)","DOI":"10.7326\/0003-4819-122-3-199502010-00011"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group. Am J Cardiol 1985; 55: 1-15.","DOI":"10.1016\/0002-9149(85)90290-5"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA 1982; 248: 1465-77.","DOI":"10.1001\/jama.1982.03330120023025"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Siscovick DS, Raghunathan TE, Psaty BM, <i>et al<\/i>. Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med 1994; 330: 1852-7.","DOI":"10.1056\/NEJM199406303302603"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100: 1311-5.","DOI":"10.1161\/01.CIR.100.12.1311"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Seeland U, Kouchi I, Zolk O, Itter G, Linz W, B\u00f6hm M. Effect of ramipril and furosemide treatment on interstitial remodeling in postinfarction heart failure rat hearts. J Mol Cell Cardiol 2002; 34: 151-63.","DOI":"10.1006\/jmcc.2001.1497"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. McCurley JM, Hanlon SU, Wei SK, Wedam EF, Michalski M, Haigney MC. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J Am Coll Cardiol 2004; 44: 1301-7.","DOI":"10.1016\/j.jacc.2004.04.059"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Francis GS, Siegel RM, Goldsmith SR, Olivari MT, Levine TB, Cohn JN. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure. Activation of the neurohumoral axis. Ann Intern Med 1985; 103: 1-6.","DOI":"10.7326\/0003-4819-103-1-1"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Tsutsui T, Tsutamoto T, Maeda K, Kinoshita M. Comparison of neurohumoral effects of short-acting and long-acting loop diuretics in patients with chronic congestive heart failure. J Cardiovasc Pharmacol 2001; 38: S81-5.","DOI":"10.1097\/00005344-200110001-00017"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yoshida J, Yamamoto K, Mano T, <i>et al<\/i>. Different effects of long- and short-acting loop diuretics on survival rate in Dahl high-salt heart failure model rats. Cardiovasc Res 2005; 68: 118-27.","DOI":"10.1016\/j.cardiores.2005.05.023"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hisatake S, Nanjo S, Fujimoto S, <i>et al<\/i>. Comparative analysis of the therapeutic effects of long-acting and short-acting loop diuretics in the treatment of chronic heart failure using (123) I-metaiodobenzylguanidine scintigraphy. Eur J Heart Fail 2011; 13: 892-8.","DOI":"10.1093\/eurjhf\/hfr054"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Miyata M, Sasaki T, Ikeda Y, <i>et al<\/i>. Comparative study of therapeutic effects of short- and long-acting loop diuretics in outpatients with chronic heart failure (COLD-CHF). J Cardiol 2012; 59: 352-8.","DOI":"10.1016\/j.jjcc.2011.12.007"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Masuyama T, Tsujino T, Origasa H, <i>et al<\/i>. Superiority of long-acting to short-acting loop diuretics in the treatment of congestive heart failure. Circ J 2012; 76: 833-42.","DOI":"10.1253\/circj.CJ-11-1500"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Abraham WT, Fisher WG, Smith AL, <i>et al<\/i>. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002; 346: 1845-53.","DOI":"10.1056\/NEJMoa013168"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Cleland JG, Daubert JC, Erdmann E, <i>et al<\/i>. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-49.","DOI":"10.1056\/NEJMoa050496"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Bristow MR, Saxon LA, Boehmer J, <i>et al<\/i>. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-50.","DOI":"10.1056\/NEJMoa032423"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Mond HG, Proclemer A. The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: calendar year 2009--a World Society of Arrhythmia\u2019s project. Pacing Clin Electrophysiol 2011; 34: 1013-27.","DOI":"10.1111\/j.1540-8159.2011.03150.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Whellan DJ, Ousdigian KT, Al-Khatib SM, <i>et al<\/i>. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) study. J Am Coll Cardiol 2010; 55: 1803-10.","DOI":"10.1016\/j.jacc.2009.11.089"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kr\u00fcck F, Bablok W, Besenfelder E, Betzien G, Kaufmann B. Clinical and pharmacological investigations of the new saluretic azosemide. Eur J Clin Pharmacol 1978; 14: 153-61.","DOI":"10.1007\/BF02089953"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tomiyama H, Nakayama T, Watanabe G, <i>et al<\/i>. Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure. Am Heart J 1999; 137: 543-8.","DOI":"10.1016\/S0002-8703(99)70504-1"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Whellan DJ, O\u2019Connor CM, Ousdigian KT, Lung TH. Rationale, design, and baseline characteristics of a Program to Assess and Review Trending INformation and Evaluate Cor-Relation to Symptoms in Patients with Heart Failure (PARTNERS HF). Am Heart J 2008; 156: 833-9.","DOI":"10.1016\/j.ahj.2008.06.036"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975; 37: 1022-36.","DOI":"10.1136\/hrt.37.10.1022"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1979; 1: 1374-6.","DOI":"10.1016\/S0140-6736(79)92010-5"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol 1978; 41: 233-43.","DOI":"10.1016\/0002-9149(78)90162-5"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353: 9-13.","DOI":"10.1016\/S0140-6736(98)11181-9"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999; 353: 2001-7.","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Goldstein S, Fagerberg B, Hjalmarson A, <i>et al<\/i>. Metoprolol controlled release\/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study. J Am Coll Cardiol 2001; 38: 932-8.","DOI":"10.1016\/S0735-1097(01)01516-9"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Brodine WN, Tung RT, Lee JK, <i>et al<\/i>. Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II). Am J Cardiol 2005; 96: 691-5.","DOI":"10.1016\/j.amjcard.2005.04.046"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Nasr IA, Bouzamondo A, Hulot JS, Dubourg O, Le Heuzey JY, Lechat P. Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis. Eur Heart J 2007; 28: 457-62.","DOI":"10.1093\/eurheartj\/ehl484"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Aleong RG, Sauer WH, Sauer WH, <i>et al<\/i>. Prevention of atrial fibrillation by bucindolol is dependent on the beta<sub>1<\/sub>389 Arg\/Gly adrenergic receptor polymorphism. JACC Heart Fail 2013; 1: 338-44.","DOI":"10.1016\/j.jchf.2013.04.002"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Studies of left ventricular dysfunction (SOLVD)--rationale, design and methods: two trials that evaluate the effect of enalapril in patients with reduced ejection fraction. Am J Car-diol 1990; 66: 315-22.","DOI":"10.1016\/0002-9149(90)90842-O"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 1991; 325: 293-302.","DOI":"10.1056\/NEJM199108013250501"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003; 42: 705-8.","DOI":"10.1016\/S0735-1097(03)00765-4"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/2\/58_16-290\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T12:47:35Z","timestamp":1498394855000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/58\/2\/58_16-290\/_article"}},"subtitle":["A Crossover Study"],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-290","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017]]}}}